相关实验视频
Updated: Jan 10, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.1K
探索ACT得分在改善喘儿童肺功能中的指示性作用,这些儿童接受了粉尘虫免疫治疗
Peilin Zhang1, Tao Ai2, Li Wang1
1Pediatric Respiratory Medicine Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.
BMC pediatrics
|November 25, 2025
概括
粉尘虫免疫疗法显著改善了患有喘的儿童的肺功能. 喘控制测试 (ACT) 的得分有助于确定从这种治疗中受益最多的儿童,特别是那些得分较高的儿童.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 免疫疗法研究 免疫疗法研究
背景情况:
- 喘影响了许多儿童,灰尘是一种常见的过敏原.
- 有效的管理策略,包括免疫疗法,对于改善肺功能至关重要.
- 喘控制水平在预测治疗反应中的作用需要进一步阐明.
研究的目的:
- 调查喘控制测试 (ACT) 得分对患有喘儿童粉尘虫免疫治疗疗效的预测值.
- 为了比较不同ACT分数的儿童的肺功能恢复,有或没有灰尘虫免疫治疗.
- 建立一种更精确的方法来选择用于粉尘虫免疫治疗的候选者.
主要方法:
- 200名患有喘和阳性粉尘过敏测试的儿童被分为观察 (免疫疗法) 和对照组.
- 根据治疗前的ACT分数进一步分层组:ACT > 19和ACT ≤ 19.
- 肺功能参数和分数呼出的氧化 (FeNO) 在随访前一年后被评估.
主要成果:
- 160名儿童完成了这项研究. 与对照组相比,免疫疗法在两个ACT得分组中改善了肺功能 (FVC,FEV1,FEF50,FEF25).
- 与对照组相比,在ACT ≤ 19的免疫治疗组中观察到多个肺功能参数 (FVC,FEV1,FEF75,FEF50,FEF25,MMEF) 和FeNO的显著改善.
- 在对照组中,ACT> 19的儿童在FEV1和FEF75的改善较小,与ACT ≤ 19的儿童相比.
结论:
- 粉尘虫免疫疗法有效提高患有喘的儿童的肺功能.
- 喘控制测试 (ACT) 得分可以作为选择那些可能特别受益于粉尘虫免疫治疗的儿童的指标.
- 进一步的研究可以根据喘控制水平完善患者选择免疫疗法.
相关概念视频
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K

